Healthcare and treatment experiences among people diagnosed with HIV before and after a province-wide treatment as prevention initiative in British Columbia, Canada

Healthcare and treatment experiences among people diagnosed with HIV before and after a province-wide treatment as prevention initiative in British Columbia, Canada

Abstract Introduction In 2010, the Canadian province of British Columbia (BC) initiated the Seek and Treat for Optimal Prevention of HIV/AIDS (STOP HIV/AIDS) program to improve HIV testing, linkage to care, and treatment uptake, thereby operationalizing the HIV Treatment as Prevention (TasP) framewo...

Full description

Bibliographic Details
Main Authors:	Tessa Tattersall, Clara Tam, David Moore, Tim Wesseling, Sean Grieve, Lu Wang, Nic Bacani, Julio S. G. Montaner, Robert S. Hogg, Rolando Barrios, Kate Salters
Format:	Article
Language:	English
Published:	BMC 2022-05-01
Series:	BMC Public Health
Subjects:	HIV/AIDS Patient care experiences ART initiation Virologic suppression Treatment as Prevention (TasP)
Online Access:	https://doi.org/10.1186/s12889-022-13415-2

Similar Items

Cohort profile: the STOP HIV/AIDS Program Evaluation (SHAPE) study in British Columbia, Canada
by: Kate Salters, et al.
Published: (2020-05-01)

It’s all about connection: Determinants of social support and the influence on HIV treatment interruptions among people living with HIV in British Columbia, Canada
by: Clara Tam, et al.
Published: (2023-12-01)

Sexual behaviour and STIs among MSM living with HIV in the PrEP era: the French ANRS PRIMO cohort study
by: Virginie Baltes, et al.
Published: (2024-03-01)

Characterizing opioid agonist therapy uptake and factors associated with treatment retention among people with HIV in British Columbia, Canada
by: Kiana Yazdani, et al.
Published: (2023-10-01)

Vital need to engage the community in HIV control in South Africa
by: Stefan Hanson, et al.
Published: (2015-08-01)

The opioid crisis is driving mortality among under-served people living with HIV in British Columbia, Canada
by: Kate A. Salters, et al.
Published: (2021-04-01)

Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
by: Jiang J, et al.
Published: (2021-03-01)

Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada.
by: Viviane D Lima, et al.
Published: (2010-06-01)

Identification of people with low prevalence diseases in administrative healthcare records: A case study of HIV in British Columbia, Canada
by: Scott D. Emerson, et al.
Published: (2023-01-01)

Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada.
by: Wendy Zhang, et al.
Published: (2012-01-01)

Process description of developing HIV prevention monitoring indicators for a province-wide pre-exposure prophylaxis (PrEP) program in British Columbia, Canada
by: Lalani L. Munasinghe, et al.
Published: (2023-01-01)

Process description of developing HIV prevention monitoring indicators for a province-wide pre-exposure prophylaxis (PrEP) program in British Columbia, Canada.
by: Lalani L Munasinghe, et al.
Published: (2023-01-01)

Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development
by: Connie G. Chiu, et al.
Published: (2017-04-01)

Detection of HIV transmission hotspots in British Columbia, Canada: A novel framework for the prioritization and allocation of treatment and prevention resources
by: Angela McLaughlin, et al.
Published: (2019-10-01)

Low Prevalence of Pre-Treatment and Acquired Drug Resistance to Dolutegravir among Treatment Naïve Individuals Initiating on Tenofovir, Lamivudine and Dolutegravir in Zimbabwe
by: Vinie Kouamou, et al.
Published: (2023-09-01)

Dynamic Modulation of Mouse Locus Coeruleus Neurons by Vasopressin 1a and 1b Receptors
by: Elba Campos-Lira, et al.
Published: (2018-12-01)

Four Decades, Four Places and Four Concepts
by: Manfred Mutter
Published: (2013-12-01)

Breast cancer treatment and ethnicity in British Columbia, Canada
by: Barroetavena Maria, et al.
Published: (2010-04-01)

Virological Non-Suppression, Non-Adherence and the Associated Factors Among People Living with HIV on Dolutegravir-Based Regimens: A Retrospective Cohort Study
by: Kabiibi F, et al.
Published: (2024-03-01)

State Capture and Corruption in (North) Macedonia* during Zoran Zaev’s Rule (2017-2021)
by: Zhidas Daskalovski, et al.
Published: (2023-12-01)

Evolution versus Design: Template-Directed Self-Assembly of Peptides to Artificial Proteins (TASP)
by: Manfred Mutter, et al.
Published: (2000-10-01)

Cloning, and Molecular Characterization of Polymorphic Iranian Isolate Theileria annulata Surface Protein (Tasp)
by: E Ebrahimzadeh, et al.
Published: (2012-06-01)

The potential impact of initiating antiretroviral therapy with integrase inhibitors on HIV transmission risk in British Columbia, Canada
by: Jielin Zhu, et al.
Published: (2019-08-01)

Gender inequities in quality of care among HIV-positive individuals initiating antiretroviral treatment in British Columbia, Canada (2000-2010).
by: Allison Carter, et al.
Published: (2014-01-01)

Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015
by: Lilian Bulage, et al.
Published: (2017-05-01)

Prediction, Synthesis and Evaluation of a Synthetic Peptide as an Enzyme-Linked Immunosorbent Assay (ELISA) Candidate for Screening of Bovine Antibodies against <i>Theileria annulata</i>
by: Prasanta Kumar Koustasa Mishra, et al.
Published: (2023-10-01)

Cloning, and Molecular Characterization of Polymorphic Iranian Isolate Theileria annulata Surface Protein (Tasp)
by: N Sadr-Shirazi, et al.
Published: (2012-06-01)

HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study
by: Adwoa K. A. Afrane, et al.
Published: (2021-08-01)

The telomere complex and the origin of the cancer stem cell
by: A. Torres-Montaner
Published: (2021-11-01)

The cost of firearm violent crime in British Columbia, Canada
by: Fahra Rajabali, et al.
Published: (2023-01-01)

Virological Outcomes Among Pregnant Women Receiving Antiretroviral Treatment in the Amhara Region, North West Ethiopia
by: Endalamaw Alamneh D, et al.
Published: (2023-05-01)

Expanding access to healthcare for people who use drugs and sex workers: hepatitis C elimination implications from a qualitative study of healthcare experiences in British Columbia, Canada
by: Nance E. Cunningham, et al.
Published: (2024-04-01)

Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment
by: Siphamandla B. Gumede, et al.
Published: (2020-08-01)

Antipsychotic profiles of TASP0443294, a novel and orally active positive allosteric modulator of metabotropic glutamate 2 receptor
by: Hirohiko Hikichi, et al.
Published: (2015-03-01)

Treatment pattern trends of medications for type 2 diabetes in British Columbia, Canada
by: Ken Bassett, et al.
Published: (2022-11-01)

Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV
by: Carlos Dueñas-Gutiérrez, et al.
Published: (2023-04-01)

Virological Non-Suppression among Newly Diagnosed HIV-Positive Individuals on Dolutegravir-Based Antiretroviral Treatment in Eastern Ethiopia: Follow-Up Study
by: Abdella Gemechu, et al.
Published: (2023-07-01)

Suppression of hTAS2R16 Signaling by Umami Substances
by: Mee-Ra Rhyu, et al.
Published: (2020-09-01)

“Virological Outcomes Among Pregnant Women Receiving Antiretroviral Treatment in the Amhara Region, North West Ethiopia” by Alamneh et al [Letter]
by: Wake AD
Published: (2023-05-01)

Infections in the natural environment of British Columbia, Canada
by: Nevio Cimolai, et al.
Published: (2008-01-01)